| Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae |
89 |
| Changes in the epidemiological landscape of invasive candidiasis |
65 |
| A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance |
64 |
| Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae |
55 |
| European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia |
50 |
| Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party |
47 |
| Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? |
46 |
| Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care |
42 |
| MIC-based dose adjustment: facts and fables |
41 |
| A multiplex lateral flow immunoassay for the rapid identification of NDM KPC IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae |
38 |
| Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin |
37 |
| Role of bacterial efflux pumps in biofilm formation |
34 |
| Molecular relatedness of ESBL/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis |
33 |
| Discovery and development of new antibacterial drugs: learning from experience? |
32 |
| Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms |
32 |
| Impact of antimicrobial therapy on the gut microbiome |
31 |
| Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care |
30 |
| Potential for reducing inappropriate antibiotic prescribing in English primary care |
30 |
| Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors |
28 |
| Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307 |
27 |
| Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens |
24 |
| In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment |
24 |
| Daptomycin |
23 |
| Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan |
23 |
| Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa |
22 |
| ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients |
20 |
| Therapeutic drug monitoring of beta-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures |
20 |
| Driving sustainable change in antimicrobial prescribing practice: how can social and behavioural sciences help? |
20 |
| Quantitative and qualitative analysis of antimicrobial usage patterns in 180 selected farrow-to-finish pig farms from nine European countries based on single batch and purchase data |
20 |
| Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers |
19 |
| Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae |
19 |
| Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program |
19 |
| Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16 |
19 |
| Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection |
17 |
| Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL) |
17 |
| Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients |
17 |
| Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes an other resistance mechanisms |
17 |
| In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstreann infections in Taiwan |
17 |
| Whole genome assembly and functional portrait of hypervirulent extensively drug-resistant NDM-1 and KPC-2 co-producing Klebsiella pneumoniae of capsular serotype K2 and ST86 |
16 |
| Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis |
16 |
| Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15 |
16 |
| Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis |
16 |
| Diagnosis and treatment of invasive fungal infections: looking ahead |
15 |
| Factors associated with antibiotic prescribing for adults with acute conditions: an umbrella review across primary care and a systematic review focusing on primary dental care |
15 |
| Time trends and geographical variation in prescribing of antibiotics in England 1998-2017 |
15 |
| In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15 |
15 |
| On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections |
15 |
| MALDI-TOF for the rapid detection of carbapenemase-producing Enterobacteriaceae: comparison of the commercialized MBT STAR (R)-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC (R) CARBA NP |
15 |
| Emergence of bla(CTX-M-55) associated with fosA, rmtB and mcr gene variants in Escherichia coli from various animal species in France |
15 |
| Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia |
14 |
